Micro Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
Micro Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 33 micro cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap under $250M — worth a combined $2.13B.
The largest by market cap are Cardiol Therapeutics (CRDL) at $234M, Organogenesis Holdings (ORGO) at $224M and SIGA Technologies (SIGA) at $218M.
Among institutional investors, Organogenesis Holdings (ORGO) drew the most net new fund positions in Q2 2026: 31 funds opened new positions, taking total fund holders up 14 (12%) quarter-over-quarter.
- Combined market cap: $2.13B across 33 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Cardiol Therapeutics (CRDL), $234M market cap.
- Most net new fund positions in Q2 2026: Organogenesis Holdings (ORGO), +14 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.